Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,177 | 910 | 653 | 653 | 334 |
| Accounts receivable | 370 | -347 | -87 | 52 | -292 |
| Accounts payable and accrued liabilities | 46 | 291 | 124 | 62 | N/A |
| Other Working Capital | 524 | -258 | -79 | 320 | -306 |
| Other Operating Activity | -6,230 | -4,761 | -2,565 | -1,774 | -1,431 |
| Operating Cash Flow | $-4,113 | $-4,165 | $-1,954 | $-686 | $-1,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -148 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 0 | 490 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -9 |
| Purchase Sale Intangibles | -80 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2 | 0 | 34 | -1 | -4 |
| Investing Cash Flow | $-230 | $490 | $34 | $-1 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -111 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,242 | 3,695 | 2,489 | 503 | 1,480 |
| Other Financing Activity | 128 | 1,798 | -97 | 88 | 5 |
| Financing Cash Flow | $2,259 | $5,494 | $2,391 | $590 | $1,485 |
| Beginning Cash Position | 2,296 | 477 | 5 | 101 | 323 |
| End Cash Position | 212 | 2,296 | 477 | 5 | 101 |
| Net Cash Flow | $-2,084 | $1,819 | $472 | $-96 | $-222 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,113 | -4,165 | -1,954 | -686 | -1,695 |
| Capital Expenditure | -228 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,340 | -4,165 | -1,954 | -686 | -1,695 |